SCWorx (NASDAQ:WORX) Rating Increased to Sell at Wall Street Zen

SCWorx (NASDAQ:WORX) was upgraded by stock analysts at Wall Street Zen to a “sell” rating in a note issued to investors on Saturday.

SCWorx Trading Down 7.0%

Shares of WORX stock opened at $0.46 on Friday. SCWorx has a 1 year low of $0.39 and a 1 year high of $3.31. The firm’s 50 day moving average is $0.58 and its 200-day moving average is $1.11. The firm has a market capitalization of $1.67 million, a price-to-earnings ratio of -0.53 and a beta of 2.37.

SCWorx (NASDAQ:WORX) last announced its earnings results on Thursday, May 15th. The company reported ($0.25) earnings per share (EPS) for the quarter. SCWorx had a negative return on equity of 89.71% and a negative net margin of 108.84%. The company had revenue of $0.72 million for the quarter.

Hedge Funds Weigh In On SCWorx

An institutional investor recently bought a new position in SCWorx stock. Renaissance Technologies LLC purchased a new position in shares of SCWorx Corp. (NASDAQ:WORX) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 20,590 shares of the company’s stock, valued at approximately $35,000. Renaissance Technologies LLC owned about 1.11% of SCWorx at the end of the most recent reporting period. 1.88% of the stock is currently owned by hedge funds and other institutional investors.

SCWorx Company Profile

SCWorx Corp. develops and markets health care information technology solutions and related services to improve healthcare processes and information flow within hospitals and other healthcare facilities in the United States. The company provides data content and services related to repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry.